Today's reflections for tomorrow's vision.

PR Newswire | May, 2024

Health-tech innovator Remidio achieves unprecedented scale in the US with its revolutionary retinal solutions

ET Healthworld | October, 2023

Eye is emerging as an interrogative tool for conditions beyond ophthalmic diseases : Dr. Anand Sivaraman

Cision PR Newswire| January, 2023

Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval

Ophthalmology Times | December, 2022

Smartphone-based fundus camera provides Glaucoma Screening

Cision PR Newswire | July, 2022

Remidio's Medios AI shows significant promise in last-mile Screening for Referable Glaucoma

Cision PR Newswire | February, 2022

Impact of the first guided Diabetic Retinopathy screening to care continuum program within the Indian public health system

Times Of India | August 2019

BMC study helps detect diabetic blindness easily

Wired | September 2018

The NHS could learn a thing or two from India's healthcare innovators

Mobihealth News| March 2018

Study: AI and a smartphone-based device help in identifying diabetic retinopathy

The Economic Times| February 2017

How potential entrepreneurs can tap India's affordable medical devices market.

The Economic Times| August 2015

Remidio Innovative Solutions: A startup providing cure for retinopathy

‍

Detecting DR With Smartphone-Based Widefield Imaging

Authors: AAO team

Artificial Intelligence in Ophthalmology: Opportunities & Challenges

Authors: Sreetama Dutt, Dr Anand Sivaraman

Tear Proteasome Analysis & its role in Early Screening & Staging of Disease

Authors: Sreetama Dutt, Dr Anand Sivaraman

The Eye as a Window to Wellness

Authors: Sreetama Dutt, Dr Anand Sivaraman